Allen Lutz
BofA Securities, Research Division

My name is Allen Lutz, I run Healthcare Tech and Distribution here at Bank of America. We are very excited to have Cardinal Health here. We have CFO, Aaron Alt and VP of Investor Relations, Dave Frost. I'm going to hand it over to David quickly for a quick disclosure.

David Frost

Thanks for having us Allen, and it's great to be here, it's great to be here. Before we begin, a little housekeeping. We'll be making forward-looking statements today, which are subject to risks and uncertainties that could cause our actual results to differ materially from these projected or implied. For a description of these factors, please review our SEC filings, which can be found on our Investor Relations website at ir.cardinalhealth.com. And with that, we can get started.

Allen Lutz
BofA Securities, Research Division

All right. I think Aaron has some opening comments.

Aaron Alt
Chief Financial Officer

Great. Good morning. Thank you all for being here. Before we delve into the Q&A, I just want to observe that having released earnings now just a couple of days ago, we feel really good about our Q3 results, right? We delivered a strong quarter across our enterprise. Our Pharma business delivered profit growth of 18%. Our other business grew affectionately known as other, our 3 growth businesses, grew profit more than 30% as well, and we continue to deliver against the GMPD execution improvement -- execution of the GMPD improvement plan, which is critical to our overall efforts.

At the same time, we also have